Search results

Biochemical and structural studies to elucidate protein interactions of the new compounds and target molecules included X-ray diffraction at the Australian Synchrotron.

ANSTO’s National Deuteration Facility has provided deuterated cholesterol for international research to gain a better understanding of how the Spike protein of the COVID virus, SARS-Co-V-2, infects human cells through a membrane fusion mechanism.

In part 1 of this two-part series, ANSTO scientists from across the organisation became film critics to review Christopher Nolan’s new movie, Oppenheimer, which explores the life of the director of the Manhattan Project to develop an atomic weapon.

The ANSTO Awards in Nuclear Science and Technology 2018 were presented on Friday 2 November at The Australian Museum, and showcased ANSTO’s unique nuclear science and technology capabilities, which enable progress in the key areas of health research and innovation for industry.

ANSTO environmental scientists have alerted the scientific community of the critical need to monitor changes to ice containing potential nuclear fallout that reached Antarctica from 20th century atmospheric weapons testing.

The celebration of the UN’s International Women’s Day 2023 has a theme that highlights the power of innovative IT to combat discrimination and the marginalisation of women globally.

Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia

ANSTO scientists are participating investigators in three new ARC Industrial Transformation Training Centres, recently announced by the Government.

ANSTO is collaborating on a project funded with an Australian Research Council linkage grant that will develop new materials and better systems for efficiently storing hydrogen gas.

ANSTO is participating in a new Australian Research Council (ARC) Centre of Excellence for Indigenous and Environmental Histories and Futures (CIEHF) to be headquartered at James Cook University (JCU) that aims to bring Indigenous and environmental histories to the forefront of land and sea management.

ANSTO offers accelerator-based particle-induced gamma-ray emission techniques to determine total fluorine concentration in a range of solid materials and rapidly screen for the presence of PFAS (perfluoroalkyl and polyfluoroalkyl substances).

Combining scientific expertise with more than $1.3 billion in unique operational assets to provide optimal radioactive waste solutions.

Researchers from the Health Research and Technology Group at ANSTO and the University of Wollongong have developed a new device that could improve the quality control of accelerator-based boron neutron capture therapy, a promising radiation therapy for treating aggressive cancers. 

An investment that will secure the long term sustainability of nuclear medicine supply in Australia.

Our people, the custodians of Australia’s nuclear and accelerator expertise, are amongst our nation’s most talented researchers, scientists, engineers and nuclear experts. Everyday we work to respond to the growing nuclear science and technology needs of Australia and the world.

To enable the production of nuclear medicine, ANSTO operates manufacturing, processing and distribution facilities in Sydney.

University of Melbourne researchers have investigated a method to produce magnetic nanoparticles in Australia for use in COVID-19 PCR tests.